Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genicon Sciences was a private life science tools company based in San Diego, California that developed, manufactured, and distributed bioassay products, instrumentation, software, and services for the biotechnology, genomics, proteomics, and clinical diagnostics markets. Its core technology was Resonance Light Scattering (RLS), an ultra-sensitive nanoparticle-based signal generation and detection platform designed for use across molecular assay formats including microarray, microfluidic, membrane, high-throughput screening, protein, DNA-based, and cellular assays. The company appears to have commercialized research-use and assay-enabling products rather than therapeutics, so it was not a drug-development biotech in the traditional sense. Genicon Sciences was later acquired through an asset purchase by Invitrogen, and the original standalone company is no longer active as an independent operating business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genicon Sciences.